Search Within

Gregory J Riely

Formats
  1. Journal Article (291)
  2. Meeting Abstract (264)
  3. Book Section (16)
  4. Guidelines (14)
  5. Conference Paper (4)
  6. Review (4)
  7. Editorial (3)
  8. Book Whole (1)
  9. Correspondence (1)
  10. Research Letter (1)
Groups
  1. Department of Medicine (599)
  2. Solid Tumor Oncology Division (599)
  3. Thoracic Oncology (599)
  4. Department of Pathology and Laboratory Medicine (260)
  5. GSK Faculty (244)
  6. Human Oncology and Pathogenesis Program (219)

More Groups

People
  1. Mark Kris (220)
  2. Marc Ladanyi (187)
  3. Helena Yu (107)
  4. Maria Arcila (85)
  5. Vincent Miller (79)
  6. Charles Rudin (75)

More People

Years
  1. 2025 (3)
  2. 2024 (25)
  3. 2023 (45)
  4. 2022 (39)
  5. 2021 (41)
  6. 2020 (29)

More Years

Publications
  1. Journal of Clinical Oncology (156)
  2. Journal of Thoracic Oncology (112)
  3. Clinical Cancer Research (46)
  4. Annals of Oncology (31)
  5. Journal of the National Comprehensive Cancer Network (25)
  6. Cancer Research (14)

More Publications

Publishers
  1. American Society of Clinical Oncology (173)
  2. Elsevier Inc. (136)
  3. American Association for Cancer Research (77)
  4. Oxford University Press (38)
  5. Harborside Press (25)
  6. Elsevier Science, Inc. (23)

More Publishers

Results (599)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Frequency of EGFR and KRAS mutations in lung adenocarcinomas in african americans
    Journal Article

    Reinersman, J. M.; Johnson, M. L.; Riely, G. J.; Chitale, D. A.; Nicastri, A. D.; Soff, G. A.; Schwartz, A. G.; Sima, C. S.; Ayalew, G.; Lau, C.; more...
    Journal of Thoracic Oncology (2011)

    Fulltext@MSK | Save
  • Erlotinib at a dose of 25 mg daily for non-small cell lung cancers with EGFR mutations
    Meeting Abstract

    Yeo, W.; Riely, G. J.; Yeap, B.; Lau, M. W.; Warner, J.; Bodio, K. A.; Kris, M. G.; Pao, W.; Kobayashi, S.; Costa, D. B.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Phase II trial of cetuximab and erlotinib in patients with lung adenocarcinoma and acquired resistance to erlotinib
    Meeting Abstract

    Riely, G. J.; Janjigian, Y. Y.; Azzoli, C. G.; Pietanza, M.; Krug, L. M.; Rizvi, N. A.; Kris, M. G.; Miller, V. A.; Pao, W.; Ginsberg, M. S.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Prognostic implications of mutations in the epidermal growth factor receptor (EGFR) and KRAS among never-smokers with adenocarcinoma of the lung
    Meeting Abstract

    Paik, P. K.; Johnson, M. L.; D'Angelo, S. P.; Sima, C.; Janjigian, Y. Y.; Riely, G. J.; Kris, M. G.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Clinical course of patients (pts) with acquired resistance (AR) to EGFR tyrosine kinase inhibitors (TKI)
    Meeting Abstract

    Oxnard, G. R.; Riely, G. J.; Arcila, M. H.; Kris, M. G.; Pao, W.; Ladanyi, M.; Miller, V. A.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • EGFR mutations in men and cigarette smokers with lung adenocarcinoma
    Meeting Abstract

    Pietanza, M.; D'Angelo, S. P.; Johnson, M. L.; Paik, P. K.; Riely, G. J.; Miller, V. A.; Zakowski, M. F.; Rusch, V. W.; Ladanyi, M.; Kris, M. G.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Initial results of LC-MAP: An institutional program to routinely profile tumor specimens for the presence of mutations in targetable pathways in all patients with lung adenocarcinoma
    Meeting Abstract

    Kris, M. G.; Lau, C. Y.; Ang, D.; Brzostowski, E.; Riely, G. J.; Rusch, V. W.; Jhanwar, S.; Lash, A.; Zakowski, M. F.; Ladanyi, M.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Association of KRAS and EGFR mutations with survival in patients with advanced lung adenocarcinoma
    Meeting Abstract

    Johnson, M. L.; Sima, C.; Paik, P. K.; Janjigian, Y. Y.; Pao, W.; Kris, M. G.; Ladanyi, M.; Riely, G. J.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Impact of EGFR and KRAS mutations on survival in 1,000 patients with resected lung adenocarcinoma
    Meeting Abstract

    D'Angelo, S. P.; Janjigian, Y. Y.; Kris, M. G.; Pao, W.; Riely, G. J.; Marks, J.; Sima, C.; Dycoco, J.; Park, B. J.; Azzoli, C. G.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Signet ring cell features (SRCF) in lung adenocarcinoma: A cytologic feature or a histologic subtype?
    Meeting Abstract

    Cohen, P. R.; Yoshizawa, A.; Motoi, N.; Riely, G. J.; Kris, M. G.; Park, B. J.; Rusch, V. W.; Travis, W. D.
    Modern Pathology (2010)

    Fulltext@MSK | Save